Evidence map›Paper›PMID 39669817›Full record

ReviewCureus2024

The Role of Nanoparticles in Accelerating Tissue Recovery and Inflammation Control in Physiotherapy Practices.

Jyothsna Volisha Cardoza, Zeeshan Ali, Simi Simon, Darshni Thakkar, Sudhan S George, Samuel Paul Isaac

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jyothsna Volisha CardozaPharmacology, Krupanidhi College of Physiotherapy, Bengaluru, IND.
Zeeshan AliPhysiology, Krupanidhi College of Physiotherapy, Bengaluru, IND.
Simi SimonBiochemistry, Krupanidhi College of Physiotherapy, Bengaluru, IND.
Darshni ThakkarPhysiotherapy, Krupanidhi college of physiotherapy, Bengaluru, IND.
Sudhan S GeorgePhysiotherapy, Krupanidhi College of Physiotherapy, Bengaluru, IND.
Samuel Paul IsaacPhysiotherapy, Krupanidhi College of Physiotherapy, Bengaluru, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physiotherapy has significantly evolved since its inception in the late 19th century, expanding into various specializations such as sports, neurology, and wound care. Its primary goal is to restore or enhance bodily functions through therapeutic interventions, aiding in conditions ranging from injuries to chronic pain. Tissue recovery, which involves repair and regeneration, is a critical aspect of physiotherapy. This natural process is influenced by factors like inflammation and injury severity. Nanotechnology, a relatively recent advancement, has transformed medicine, including wound care, through innovations in drug delivery, diagnostics, and anti-inflammatory treatments. Nanoparticles, owing to their small size and enhanced bioavailability, play a crucial role in improving drug delivery, increasing the efficacy of treatments, and promoting faster recovery. In the context of tissue healing, nanoparticles aid in cell proliferation, inflammation control, and scar reduction, among other therapeutic benefits. They are increasingly used in physiotherapy applications, to support tissue regeneration and inflammation management. This review examines the role of nanoparticles in physiotherapy, with a focus on their application in wound healing, muscle recovery, and inflammation control. It discusses various in-vitro and in-vivo studies that have explored the therapeutic potential of nanoparticles in these domains, providing insights into their mechanisms of action and effectiveness in promoting tissue regeneration and managing inflammation in physiotherapy settings.

Indexed as

inflammationnanoparticlespain managementphysiotherapytissue recovery

Identifiers

PMID39669817
PMCPMC11636964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.